The U.S. Food and Drug Administration (FDA) has approved darolutamide,...
The U.S. Food and Drug Administration recently cleared for marketing f...
Pfizer Inc. has announced the successful completion of its acquisition...
Hillrom announced that its latest innovation in vision screening and d...
Roche has announced that the Global Access Program is expanding beyond...
Hikma Pharmaceuticals PLC the multinational pharmaceutical company, ha...
Hikma Pharmaceuticals PLC,the multinational generic pharmaceutical com...
The medical laboratories market is growing rapidly in the Asia-Pacific...
Curza, a privately-held small-molecule drug development company focuse...
Allergan plc (NYSE: AGN) has announced a voluntary worldwide reca...
Dassault Systèmes has announced the five-year extension of its ...
As a pioneer in the Enteric Dialysis® platform technology, Ki...
Sanofi signed an agreement with Roche for the exclusive over-the-count...
Yellow Wood Partners has entered into a definitive agreement to buy th...
Based on new evidence assessing benefits and risks, the WHO recommends...
Gilead Sciences, Inc. has announced today that it has licensed three p...
TransPerfect Medical Device Solutions (MDS), the world's largest provi...
Boehringer Ingelheim and Bridge Biotherapeutics Inc. have announced th...
